4.7 Review

Diagnosis and Management of Prediabetes A Review

Journal

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 329, Issue 14, Pages 1206-1216

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jama.2023.4063

Keywords

-

Ask authors/readers for more resources

Prediabetes, an intermediate stage between normal glucose regulation and diabetes, affects 1 in 3 adults in the US and approximately 720 million individuals worldwide. Lifestyle modification, including weight loss and exercise, is the first-line therapy for prediabetes and has a larger benefit than metformin.
IMPORTANCE Prediabetes, an intermediate stage between normal glucose regulation and diabetes, affects 1 in 3 adults in the US and approximately 720 million individuals worldwide. OBSERVATIONS Prediabetes is defined by a fasting glucose level of 100 to 125mg/dL, a glucose level of 140 to 199mg/dL measured 2 hours after a 75-g oral glucose load, or glycated hemoglobin level (HbA(1C)) of 5.7% to 6.4% or 6.0% to 6.4%. In the US, approximately 10% of people with prediabetes progress to having diabetes each year. Ameta-analysis found that prediabetes at baselinewas associated with increased mortality and increased cardiovascular event rates (excess absolute risk, 7.36 per 10000 person-years for mortality and 8.75 per 10000 person-years for cardiovascular disease during 6.6 years). Intensive lifestyle modification, consisting of calorie restriction, increased physical activity (>= 150 min/wk), self-monitoring, and motivational support, decreased the incidence of diabetes by 6.2 cases per 100 person-years during a 3-year period. Metformin decreased the risk of diabetes among individuals with prediabetes by 3.2 cases per 100 person-years during 3 years. Metformin is most effective forwomen with prior gestational diabetes and for individuals younger than 60 years with body mass index of 35 or greater, fasting plasma glucose level of 110mg/dL or higher, or HbA(1c) level of 6.0% or higher. CONCLUSIONS AND RELEVANCE Prediabetes is associated with increased risk of diabetes, cardiovascular events, and mortality. First-line therapy for prediabetes is lifestyle modification that includes weight loss and exercise or metformin. Lifestyle modification is associated with a larger benefit than metformin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available